132 Annual Meeting Logo - Go to APHA Meeting Page  
APHA Logo - Go to APHA Home Page

Access to medicines and the financing of innovations in health care

James Love, Consumer Project on Technology, P.O. Box 19367, Washington, DC 20036, 202-387-8030, james.love@cptech.org

Rising drug costs have prevented essential medicines to parts of the world that can not afford them, and many of the diseases that are rampant in these countries are of little interest to the pharmaceutical industry because R&D will not be profitable. The Doha Declaration on Health requires that member nations implement patent laws in a way that promote public health and insures “access of medicines to all.” Financing Medical R&D depends on the enforcement of intellectual property rights, but evidence suggests that higher levels of intellectual property protections can distort the research agenda and slow the pace of follow up innovations. The presentation will discuss alternative approaches to financing R&D that are more responsive to the public’s needs and that will provide better access to essential drugs.

Learning Objectives: At the conclusion of the session, the participant in the session will

Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.

Controlling Drug Prices at Home and Abroad: Beyond Formularies and Importation (Medical Care Section Solicited Session #2)

The 132nd Annual Meeting (November 6-10, 2004) of APHA